This HTML5 document contains 17 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
dbpedia-owlhttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n7http://dbpedia.org/resource/Santa_Monica,
n8http://dbpedia.org/resource/President_(corporate_title)
rdfshttp://www.w3.org/2000/01/rdf-schema#
n5http://www.kitepharma.com/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
dbpediahttp://dbpedia.org/resource/
Subject Item
dbpedia:Kite_Pharma
rdfs:comment
Kite Pharma is a publicly held, clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products with a primary focus on engineered autologous T cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors.The Santa Monica, California-based company was founded in 2009 by Arie Belldegrun, M.D., FACS, an Israeli-American oncologist, who serves as the company's chairman, president and chief executive officer.
foaf:name
Kite Pharma, Inc.
foaf:homepage
n5:
dbpedia-owl:foundedBy
dbpedia:Arie_Belldegrun
dbpedia-owl:foundingYear
2009-01-01Z
dbpedia-owl:industry
dbpedia:Biopharmaceutical
dbpedia-owl:keyPerson
dbpedia:Chief_Medical_Officer dbpedia:Chief_executive_officer dbpedia:Chief_financial_officer dbpedia:Chief_science_officer dbpedia:Chairman dbpedia:Chief_operating_officer n8:
dbpedia-owl:locationCity
n7:_California
dbpedia-owl:locationCountry
dbpedia:California
dbpedia-owl:product
dbpedia:Cancer_immunotherapy
dbpedia-owl:type
dbpedia:Public_company